The present invention relates to compounds of the following formula (I) and/or the pharmaceutically acceptable addition salts solvates enantiomers diastereoisomers thereof as well as mixtures thereof. The subject matter of the present invention thus also includes the preparation of compounds of formula (I) their uses in particular in the inhibition of protein kinases which are implicated for example in numerous diseases such as cancers or immune system disorders.